Language selection

Government of Canada

Search

Controlled Substances Regulations (SOR/2025-242)

Regulations are current to 2026-03-17

Pharmacists and Pharmacy Technicians (continued)

Documents (continued)

Information (continued)

The following provision is not in force.

Marginal note:Prescription transfers — transferring pharmacist

  • The following provision is not in force.

     (1) A pharmacist or pharmacy technician who transfers a prescription to another pharmacist or pharmacy technician must record the following information:

    • The following provision is not in force.

      (a) their name;

    • The following provision is not in force.

      (b) with respect to the other pharmacist or pharmacy technician, their name and the name and municipal address of the place where they practise;

    • The following provision is not in force.

      (c) the number assigned to the prescription;

    • The following provision is not in force.

      (d) the date of the prescription transfer;

    • The following provision is not in force.

      (e) the date of the last refill of the prescription and, if applicable, the number of authorized refills remaining and, if specified, the interval between refills; and

    • The following provision is not in force.

      (f) if applicable, the date of the prescription extension and the new expiration date of the extended prescription.

  • The following provision is not in force.

    Marginal note:Prescription transfer — receiving pharmacist

    (2) The pharmacist or pharmacy technician who receives the transferred prescription must record the following information:

    • The following provision is not in force.

      (a) their name;

    • The following provision is not in force.

      (b) with respect to the pharmacist or pharmacy technician from whom they receive the transferred prescription, their name and the name and municipal address of the place where they practise;

    • The following provision is not in force.

      (c) the number assigned to the prescription;

    • The following provision is not in force.

      (d) the date of receipt of the prescription;

    • The following provision is not in force.

      (e) the date of the last refill of the prescription and, if applicable, the number of authorized refills remaining and, if specified, the interval between refills; and

    • The following provision is not in force.

      (f) if applicable, the date of the prescription extension and the new expiration date of the extended prescription.

The following provision is not in force.

Marginal note:Transportation

 A pharmacist or pharmacy technician who delivers, sends or transports a controlled substance must record the following information:

  • The following provision is not in force.

    (a) their name and the name and municipal address of the place where they practise;

  • The following provision is not in force.

    (b) if an agent or mandatary of the pharmacist delivers, sends or transports the controlled substance, their name;

  • The following provision is not in force.

    (c) if the controlled substance is delivered, sent or transported to another person, the following information with respect to that person:

    • (i) if it is not a person referred to in subparagraph (ii), their name and, if applicable, title, or

    • (ii) if they are an individual who is named in a prescription or who is responsible for an animal identified in a prescription, their name and, if applicable, the name of the animal;

  • The following provision is not in force.

    (d) the municipal address of the place where the controlled substance is delivered, sent or transported;

  • The following provision is not in force.

    (e) the date of the delivery, sending or transportation;

  • The following provision is not in force.

    (f) the means of transportation;

  • The following provision is not in force.

    (g) in the case of a controlled substance set out in any of Schedules 1 to 3, its name, form and quantity; and

  • The following provision is not in force.

    (h) in the case of a finished product,

    • (i) subject to subparagraph (iv), its name or, if applicable, brand name, as well as the name of the controlled substance it contains,

    • (ii) subject to subparagraph (iv), its form, its strength, the number of containers and, if applicable, the number of units per container,

    • (iii) subject to subparagraph (iv), its drug identification number, if any, and

    • (iv) if the finished product has been previously returned by an individual or particular person for the purposes of destruction, only the identifier marked on the collection container of the finished product and the number of collection containers.

The following provision is not in force.

Marginal note:Destruction

 A pharmacist or pharmacy technician who destroys a controlled substance must record the following information:

  • The following provision is not in force.

    (a) their name;

  • The following provision is not in force.

    (b) the name of the witness to the destruction;

  • The following provision is not in force.

    (c) the municipal address of the place of destruction;

  • The following provision is not in force.

    (d) the date of destruction;

  • The following provision is not in force.

    (e) the method of destruction;

  • The following provision is not in force.

    (f) in the case of a controlled substance set out in any of Schedules 1 to 3, its name and quantity; and

  • The following provision is not in force.

    (g) in the case of a finished product,

    • (i) subject to subparagraph (iv), its name or, if applicable, brand name, as well as the name of the controlled substance it contains,

    • (ii) subject to subparagraph (iv), its form, its strength, the number of containers and, if applicable, the number of units per container,

    • (iii) subject to subparagraph (iv), its drug identification number, if any, and

    • (iv) if the finished product has been previously returned by an individual or particular person for the purposes of destruction, only the identifier marked on the collection container of the finished product and the number of collection containers.

Recording Information and Retention and Provision of Documents

The following provision is not in force.

Marginal note:Method of recording

 A pharmacist or pharmacy technician who records any information under these Regulations must do so using a method that permits an audit of it to be made at any time.

The following provision is not in force.

Marginal note:Documents to retain

  • The following provision is not in force.

     (1) A pharmacist who is responsible for the operations of a pharmacy where the information was recorded under these Regulations or, if a pharmacy ceases its operations, the person who was responsible for those operations on the date those operations ceased must, subject to subsection (2), ensure that

    • The following provision is not in force.

      (a) any document containing the information that must be recorded under these Regulations is kept for two years after the day on which the last record is recorded in the document;

    • The following provision is not in force.

      (b) every written order and prescription is kept, in sequence as to date and number, for two years after the day on which it is received; and

    • The following provision is not in force.

      (c) every declaration and report is kept for two years after the day on which it is provided or received.

  • The following provision is not in force.

    Marginal note:Substances sold or provided

    (2) All documents regarding the sale or provision of a controlled substance must be kept separately, in sequence as to date and number.

The following provision is not in force.

Marginal note:Place

 The documents must be accessible

  • The following provision is not in force.

    (a) at the pharmacy where the information was recorded; or

  • The following provision is not in force.

    (b) if that pharmacy has ceased its operations, at a place in Canada.

The following provision is not in force.

Marginal note:Quality of documents

 The documents must be complete and readily retrievable and the information in them must be legible and indelible.

The following provision is not in force.

Marginal note:Providing documents

 A pharmacist who is responsible for a pharmacy’s operations or, if a pharmacy has ceased its operations, the person who was responsible for those operations on the date those operations ceased must provide any documents that the Minister requests in the time and manner that the Minister specifies.

Practitioners

Prescriptions

The following provision is not in force.

Marginal note:Conditions

 A practitioner may issue a written prescription that they sign and date or a verbal prescription if

  • The following provision is not in force.

    (a) the practitioner is treating, in their professional capacity, the individual for whom, or the animal for which, the prescription is issued; and

  • The following provision is not in force.

    (b) the controlled substance set out in the prescription is needed to treat the individual’s or animal’s medical condition.

Sale of Controlled Substances

The following provision is not in force.

Marginal note:Sale to licensed dealer

  • The following provision is not in force.

     (1) A practitioner may sell or provide a controlled substance to a licensed dealer if,

    • The following provision is not in force.

      (a) in the case of a controlled substance previously returned by an individual for the purposes of destruction,

      • (i) the licensed dealer is specialized in destruction, and

      • (ii) the practitioner first receives from that licensed dealer specialized in destruction a written order that is signed and dated and that contains the information set out in subsection (2); and

    • The following provision is not in force.

      (b) in the case of any other controlled substance,

      • (i) one of the following conditions is met:

        • (A) the licensed dealer is the one that sold or provided that controlled substance to the practitioner, or

        • (B) the practitioner sells or provides the controlled substance for the purposes of testing or destruction, and

      • (ii) the practitioner first receives from the licensed dealer a written order that is signed and dated and that contains the information set out in subsection (2).

  • The following provision is not in force.

    Marginal note:Written orders

    (2) The information that must be contained in the written order is the following:

    • The following provision is not in force.

      (a) with respect to the licensed dealer, their name and, if applicable, title, as well as their municipal address;

    • The following provision is not in force.

      (b) with respect to the practitioner, their name and the name and municipal address of the place where they practise;

    • The following provision is not in force.

      (c) the date of the order;

    • The following provision is not in force.

      (d) in the case of a controlled substance set out in any of Schedules 1 to 4, its name, form and quantity;

    • The following provision is not in force.

      (e) in the case of a finished product,

      • (i) subject to subparagraph (iv), its name or, if applicable, brand name,

      • (ii) subject to subparagraph (iv), its form, strength and quantity,

      • (iii) subject to subparagraph (iv), its drug identification number, if any, and

      • (iv) if the finished product has been previously returned by an individual for the purposes of destruction, only the identifier marked on the collection container of the finished product and the number of collection containers; and

    • The following provision is not in force.

      (f) in the case of a controlled substance sold or provided for the purposes of destruction, a statement to that effect.

The following provision is not in force.

Marginal note:Sale to Minister

 A practitioner may sell or provide a controlled substance to the Minister if they first receive from the Minister a written order that is signed and dated on the Minister’s behalf and that contains the following information:

  • The following provision is not in force.

    (a) with respect to the individual signing the order, their name and, if applicable, title, as well as the municipal address of the place where the controlled substance is to be delivered, sent or transported;

  • The following provision is not in force.

    (b) with respect to the practitioner, their name and the name and municipal address of the place where they practise;

  • The following provision is not in force.

    (c) the date of the order;

  • The following provision is not in force.

    (d) in the case of a controlled substance set out in any of Schedules 1 to 4, its name, form and quantity; and

  • The following provision is not in force.

    (e) in the case of a finished product,

    • (i) its name or, if applicable, brand name,

    • (ii) its form, strength and quantity, and

    • (iii) its drug identification number, if any.

The following provision is not in force.

Marginal note:Sale to individual

  • The following provision is not in force.

     (1) A practitioner may sell or provide a controlled substance, other than a restricted drug, to an individual if

    • The following provision is not in force.

      (a) the sale or provision is for the individual’s own use, for the use of another individual or for an animal; and

    • The following provision is not in force.

      (b) the practitioner first issues a written prescription for the individual for whom, or the animal for which, the controlled substance is sold or provided.

  • The following provision is not in force.

    Marginal note:Restricted drugs

    (2) A practitioner may sell or provide a restricted drug to an individual for their own use if

    • The following provision is not in force.

      (a) the practitioner is treating the individual in their professional capacity; and

    • The following provision is not in force.

      (b) the practitioner has received a copy of the letter of authorization in which they are named.

 

Page Details

Date modified: